#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.
RSS   Newsletter   Contact   Advertise with us

Nervgen Pharma appoints Denis Bosc as vice-president

Share on Twitter Share on LinkedIn
Christian Fernsby | Vancouver, BC, Canada | May 31, 2019
Nervgen PharmaNervgen Pharma, a pharmaceutical company, has appointed Denis Bosc as the company's vice-president, chemistry, manufacturing and control (CMC).
Dr. Bosc joins NervGen from the Centre for Probe Development and Commercialization ("CPDC"), a Canadian center of excellence for commercialization and research, where he was Director, Radiopharmaceutical Development and Supply.

Prior to CPDC, Dr. Bosc was VP, R and D at Impopharma, a company specializing in the development of nasal spray and pulmonary inhalation drug products.

Dr. Bosc's CMC experience also includes positions at Apotex Inc. and SteriMax, both commercial stage companies, YM BioSciences, a small molecule pharmaceutical company acquired by Gilead Sciences and Viventia Biotech, an antibody therapeutic development company.

Dr. Bosc received a PhD in Biochemistry and Molecular Biology, and a Bachelor of Science, Biotechnology, from the University of Manitoba.

 LATEST MOVES FROM British Columbia